CClinicalTrials.gg
CompletedNCT02630953Updated Mar 4, 2021Results posted

Culturally and Linguistically Adapted Physical Activity Intervention for Latinas

An interventional study of Original Tailored Intervention and Enhanced Tailored Intervention in Inactivity, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-04.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
214
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The overall goals of this renewal are to replicate the findings of Seamos Saludables in Latina women, increase the effectiveness of the intervention, and measure intervention-related changes in clinical biomarkers. We will enhance the existing intervention by incorporating participant feedback (desire for greater interactivity and accountability), further targeting Social Cognitive Theory (SCT) constructs that were not influenced overall by the original intervention yet improved amongst our most successful participants (social support, outcome expectancies), and responding to changing trends and technology use in Latinos. We will conduct a clinical trial among Latina women in California randomized to either 1) the original Seamos Saludables tailored print only intervention or 2) a theory and text messaging-enhanced interactive technology based version of the Seamos Saludables intervention. We will also measure changes in cardiovascular and metabolic biomarkers (e.g., HbA1c, and LDL) to assess potential clinical impact of the intervention.

Read the detailed description

Latinos are the largest racial/ethnic minority group in the U.S., and report substantial and widening health disparities. Prevalence of type II diabetes is 60-100% higher in Latinos than in non-Latino Whites, and incidence in Latinos is projected to increase by 500% by 20503. The largest disparities are projected for Latino women (Latinas). Rates of overweight and obesity are 23% and 37% higher in Latinas than in White women respectively, and have grown faster in Mexican American women, by far the largest subgroup of Latinas, than in White women during the past decade. Given that Latinos are projected to comprise nearly one-third of the US population by 2050, this signifies a pressing public health concern in terms of costs, diminished quality of life, and lost life years. Interventions are therefore needed that are not only linguistically adapted for this population but address their specific barriers. "Mediated" intervention delivery approaches (e.g., mail, phone, or web delivered) that emphasize home-based, lifestyle activities show larger effect sizes than face-to-face approaches, are more cost-effective, are likely more sustainable, and may be particularly appropriate for Latinas, as they reduce the burden of time, childcare, and transportation, barriers commonly cited by Latinas. Thus in the previously funded parent grant (R01NR011295) we responded to PAR-07-379, "Behavioral and Social Science Research on Understanding and Reducing Health Disparities," by modifying an existing print-based mail-delivered PA intervention and adapting it specifically for Latinas in the North Eastern U.S. with low acculturation, literacy, and socioeconomic status (SES), and testing the modified intervention in a randomized controlled trial (N=266). Participants in the PA intervention arm showed significantly greater increases in at least moderate intensity activity, increasing from 1.87 min/week at baseline to 73.36 min/week at 6 months (vs. 3.02 min/week to 32.98 min/week in a contact control group). However, this is still well below the national guidelines of 150 minutes per week. This intervention therefore shows potential in promoting initial PA adoption, yet enhancements are needed to further help people achieve levels of PA that will prevent disease and reduce health disparities. The objectives of this renewal are to 1) enhance the intervention to achieve greater increases in PA, 2) assess its potential clinical impact by measuring changes in biomarkers, and 3) increase its generalizability by replicating it in Latina women, all of which would further the goal of designing an innovative behavioral intervention to promote health and prevent illness in diverse populations.

02

Conditions studied

  • Inactivity

Keywords

  • Physical Activity
  • Latinas
  • Spanish-language
  • Text-Message
  • English-language
  • Exercise
03

In context

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female
  • Generally healthy (If asthma, controlled high blood pressure and/or controlled type II diabetes, may be able to participate with physician consent)
  • Sedentary (Less than 60 minutes per week of moderate or vigorous physical activity)
  • Hispanic or Latina (self-identified)
  • Must be able to read and write in English or Spanish fluently
  • 18 - 65 years of age
  • Planning on living in the area for the next 12 months
  • Own a cell phone capable of sending and receiving text messages

Exclusion criteria

Exclusion Criteria:

  • BMI greater than 45
  • Not able to walk continuously for 30 minutes/limited ability to complete daily activity or ability to exercise
  • Exercise is against advice of doctor
  • Current or planned pregnancy
  • Heart disease/treatment
  • Heart murmur
  • Angina/chest pain or Angina/chest pain with exertion
  • Palpitations
  • Stroke/Transient Ischemic Attacks
  • Peripheral Vascular Disease
  • Type I Diabetes
  • Uncontrolled Type II Diabetes
  • Chronic Infectious Disease - HIV, Hepatitis
  • Chronic liver disease
  • Cystic Fibrosis
  • Abnormal EKG on last EKG performed
  • Emphysema, Chronic bronchitis, Chronic Obstructive Pulmonary Disease
  • Seizure in past year
  • Surgery in past year on heart, lung, joint, orthopedic surgery
  • Surgery pending in next year on lung, joint, orthopedic surgery
  • Unusual/concerning shortness of breath
  • Asthma (may be able to participate with physician consent)
  • High blood pressure/high blood pressure medication (may be able to participate with physician consent)
  • Use of beta blockers
  • Abnormal Medical Stress Test
  • Musculoskeletal problems
  • Fainting/dizziness more than 3 times in past year OR interferes with daily activities OR causes loss of balance
  • Cancer treatment in past 3 months
  • Hospitalized for psychiatric disorder in past 3 years or suicidal
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
214 participants (actual)

Study arms

  • Active comparator
    Original Tailored Intervention

    This existing empirically supported Spanish-language PA intervention, which is based on Social Cognitive Theory and the Transtheoretical Model (TTM), emphasizes behavioral strategies for increasing PA levels (goal-setting, self-monitoring, problem-solving barriers, increasing social support, self-rewards for meeting PA goals).

    Behavioral: Original Tailored Intervention

  • Experimental
    Enhanced Tailored Intervention

    We designed the Enhanced Tailored Intervention to build upon our previous research in order to outperform the original tailored intervention, in a cost effective, theoretically guided and data driven manner with potential for dissemination. Participants in the Enhanced Tailored Intervention will receive an interactive technology based intervention that: 1) addresses important SCT constructs for increasing PA that were not significantly changed in the original parent trial (enjoyment/outcome expectations and social support) and 2) provides greater accountability and interactivity for self-monitoring (through text messages), as requested by participants in the original parent trial.

    Behavioral: Enhanced Tailored Intervention

Interventions

  • BehavioralOriginal Tailored Intervention

    The intervention includes regular mailings: weekly in month 1, biweekly in months 2 and 3, monthly in months 4 to 6, and a maintenance dose. Mailings consist of; 1) Manuals matched to the participant's current level of motivational readiness to change, based on TTM 2) Individually tailored computerized expert system feedback reports based on the participant's answers to monthly questionnaires. The computer expert system draws from a bank of over 330 messages developed from previous studies that address different levels of psychosocial and environmental factors affecting PA. 3) PA tip sheets addressing PA barriers specifically identified by Latinas in our formative research (e.g., caregiving duties, neighborhood safety).

  • BehavioralEnhanced Tailored Intervention

    Participants in the Enhanced Tailored arm will receive all the intervention components of the original tailored intervention, as well as: 1) additional print materials; 2) more in-depth tailored reports; and 3) text-messages. Self-monitoring was an important aspect in increasing PA in our previous trials however, participants were only asked to turn in the self-monitoring logs once a month. Based on the importance of self-monitoring and feedback from participants (R01NR011295; R01CA15994) that they wanted greater accountability and interactivity, we added a text-message component for self-monitoring.

06

What researchers measure

Primary outcomes

  1. Change in Accelerometer Measured Moderate to Vigorous PA (MVPA) by the Actigraph GT3X+

    Participants will wear an Actigraph GT3X+ accelerometer, which measures movement and intensity of activity and has been validated against heart rate telemetry and total energy expenditure.

    Time frame: Baseline, 6 months and 12 months

Secondary outcomes

  1. Change in Total Weekly Minutes of Physical Activity as Measured by the 7-Day PAR (Physical Activity Recall), From Baseline to 6-months and 12-months.

    The 7-Day PAR is an interviewer administered instrument that uses multiple strategies for increasing accuracy of participant recall regarding many types of activities such as time spent sleeping and moderate, hard, and very hard intensity activities. The 7-Day PAR is used across many studies assessing physical activity and has consistently demonstrated acceptable reliability, internal consistency, and congruent validity with other objective measures of activity levels.

    Time frame: Baseline, 6 months and 12 months

  2. Changes in Cardiovascular and Metabolic Biomarkers (e.g., HbA1c, and LDL)

    Blood samples will be collected at the baseline and 6-month clinic visits. Specifically, low-density lipoprotein cholesterol (LDL), hemoglobin A1C (HbA1c), and blood pressure will be measured. These assays will be collected by personnel at the UCSD NIH-funded Clinical and Translational Research Institute (CTRI).

    Time frame: Baseline, 6 months

  3. Changes in Cholesterol

    Blood samples will be collected at the baseline and 6-month clinic visits. Specifically, low-density lipoprotein cholesterol (LDL) will be measured. These assays will be collected by personnel at the UCSD NIH-funded Clinical and Translational Research Institute (CTRI).

    Time frame: Baseline, 6 months

  4. Changes in Triglycerides

    Blood samples will be collected at the baseline and 6-month clinic visits.

    Time frame: Baseline, 6 months

07

Results

Posted Mar 4, 2021

Participant flow

6 Month Assessment
Participant flow — 6 Month Assessment
MilestoneOriginal Tailored InterventionEnhanced Tailored Intervention
Started97102
Completed8370
Not completed1432
12 Month Assessment
Participant flow — 12 Month Assessment
MilestoneOriginal Tailored InterventionEnhanced Tailored Intervention
Started97102
Completed7364
Not completed2438

Outcome measures

PrimaryChange in Accelerometer Measured Moderate to Vigorous PA (MVPA) by the Actigraph GT3X+

Participants will wear an Actigraph GT3X+ accelerometer, which measures movement and intensity of activity and has been validated against heart rate telemetry and total energy expenditure.

Time frame:
Baseline, 6 months and 12 months
Reported as:
Median · minutes/week
Change in Accelerometer Measured Moderate to Vigorous PA (MVPA) by the Actigraph GT3X+
minutes/weekOriginal Tailored InterventionEnhanced Tailored Intervention
Baseline10 (0 to 68.50)0 (0 to 38)
6 Months36 (0 to 109.75)28 (0 to 98.50)
12 Months36 (0 to 127)40 (0 to 110)
Statistical analysis
  • Original Tailored Intervention vs Enhanced Tailored Intervention · quantile regression · p = 0.24 (Significance level was set at .05 a priori.) · Median difference (final values): -6.22 · 95% CI -41.15 to 28.70Bootstrapped standard errors (10,000 replications)
SecondaryChange in Total Weekly Minutes of Physical Activity as Measured by the 7-Day PAR (Physical Activity Recall), From Baseline to 6-months and 12-months.

The 7-Day PAR is an interviewer administered instrument that uses multiple strategies for increasing accuracy of participant recall regarding many types of activities such as time spent sleeping and moderate, hard, and very hard intensity activities. The 7-Day PAR is used across many studies assessing physical activity and has consistently demonstrated acceptable reliability, internal consistency, and congruent validity with other objective measures of activity levels.

Time frame:
Baseline, 6 months and 12 months
Reported as:
Median · minutes/week
Change in Total Weekly Minutes of Physical Activity as Measured by the 7-Day PAR (Physical Activity Recall), From Baseline to 6-months and 12-months.
minutes/weekOriginal Tailored InterventionEnhanced Tailored Intervention
Baseline0 (0 to 15)0 (0 to 20)
6 Months100 (30 to 172)110 (66 to 175)
12 Months100 (43.50 to 183)130 (45 to 195)
Statistical analysis
  • Original Tailored Intervention vs Enhanced Tailored Intervention · quantile regression · p = 0.73 (Significance was set at .05 a priori) · Median difference (final values): 7.5 · 95% CI -32.37 to 47.37
SecondaryChanges in Cardiovascular and Metabolic Biomarkers (e.g., HbA1c, and LDL)

Blood samples will be collected at the baseline and 6-month clinic visits. Specifically, low-density lipoprotein cholesterol (LDL), hemoglobin A1C (HbA1c), and blood pressure will be measured. These assays will be collected by personnel at the UCSD NIH-funded Clinical and Translational Research Institute (CTRI).

Time frame:
Baseline, 6 months
Reported as:
Mean · percentage
Changes in Cardiovascular and Metabolic Biomarkers (e.g., HbA1c, and LDL)
percentageOriginal Tailored InterventionEnhanced Tailored Intervention
Baseline A1c5.36 ± 0.385.43 ± 0.83
6 Month A1c5.35 ± 0.435.29 ± 0.27
Statistical analysis
  • Original Tailored Intervention vs Enhanced Tailored Intervention · Regression, Linear · p = >.06 (Significance level set at .05 a priori) · Mean difference (net): -.06
SecondaryChanges in Cholesterol

Blood samples will be collected at the baseline and 6-month clinic visits. Specifically, low-density lipoprotein cholesterol (LDL) will be measured. These assays will be collected by personnel at the UCSD NIH-funded Clinical and Translational Research Institute (CTRI).

Time frame:
Baseline, 6 months
Reported as:
Mean · mg/dL
Changes in Cholesterol
mg/dLOriginal Tailored InterventionEnhanced Tailored Intervention
Baseline Cholesterol188.65 ± 31.70192.00 ± 37.29
6 Month Cholesterol188.09 ± 31.17185.42 ± 38.42
Baseline HDL51.13 ± 12.5452.28 ± 54.13
6 Month HDL53.44 ± 12.3854.13 ± 13.50
Baseline LDL104.80 ± 26.56109.75 ± 30.94
6 Month LDL109.41 ± 28.43107.71 ± 31.05
SecondaryChanges in Triglycerides

Blood samples will be collected at the baseline and 6-month clinic visits.

Time frame:
Baseline, 6 months
Reported as:
Mean · mg/dL
Changes in Triglycerides
mg/dLOriginal Tailored InterventionEnhanced Tailored Intervention
Baseline Triglycerides166.58 ± 101.60149.88 ± 117.94
6 Month Triglycerides133.91 ± 90.98117.94 ± 57.40

Adverse events

Collected over 12 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Original Tailored Intervention0/97 (0%)0/97 (0%)5/97 (5.2%)
Enhanced Tailored Intervention0/102 (0%)0/102 (0%)10/102 (9.8%)
Most frequent other events
Showing 10 of 12
Most frequent other events
EventOriginal Tailored InterventionEnhanced Tailored Intervention
Knee PainMusculoskeletal and connective tissue disorders2/970/102
Leg PainMusculoskeletal and connective tissue disorders0/972/102
Knee PainMusculoskeletal and connective tissue disorders0/972/102
Heel and Back PainGeneral disorders1/970/102
Leg InjuryGeneral disorders1/970/102
Breast BiopsyReproductive system and breast disorders1/970/102
Toe PainSkin and subcutaneous tissue disorders0/971/102
Infected BladderRenal and urinary disorders0/971/102
Hip Pain and RashGeneral disorders0/971/102
Lumbar Spinal StenosisMusculoskeletal and connective tissue disorders0/971/102

Baseline characteristics

Age, Continuous
Age, Continuous(years)Original Tailored InterventionEnhanced Tailored InterventionTotal
Mean44.14 ± 9.5743.55 ± 10.6343.80 ± 10.11
Sex: Female, Male
Sex: Female, Male(Participants)Original Tailored InterventionEnhanced Tailored InterventionTotal
Female97102199
Male000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Original Tailored InterventionEnhanced Tailored InterventionTotal
Hispanic or Latino97102199
Not Hispanic or Latino000
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Original Tailored InterventionEnhanced Tailored InterventionTotal
American Indian or Alaska Native516
Asian101
Native Hawaiian or Other Pacific Islander000
Black or African American000
White454792
More than one race224
Unknown or Not Reported445296
Region of Enrollment
Region of Enrollment(participants)Original Tailored InterventionEnhanced Tailored InterventionTotal
United States97102199
Body Mass Index (BMI)
Body Mass Index (BMI)(kg/m^2)Original Tailored InterventionEnhanced Tailored InterventionTotal
Mean30.79 ± 5.1930.50 ± 9.3130.64 ± 7.56
Self Reported Min/Week MVPA
Self Reported Min/Week MVPA(minutes/week)Original Tailored InterventionEnhanced Tailored InterventionTotal
Mean10.51 ± 19.4714.33 ± 25.0612.47 ± 22.54
Objectively Measured Min/Week MVPA
Objectively Measured Min/Week MVPA(minutes/week)Original Tailored InterventionEnhanced Tailored InterventionTotal
Mean45.72 ± 70.9333.61 ± 71.2939.51 ± 71.20
08

Study locations

1 site
  • University of California San Diego
    La Jolla, California 92093-0628, United States
09

References and documents

Publications

  • Marcus BH, Dunsiger S, Pekmezi D, Benitez T, Larsen B, Meyer D. Physical activity outcomes from a randomized trial of a theory- and technology-enhanced intervention for Latinas: the Seamos Activas II study. J Behav Med. 2022 Feb;45(1):1-13. doi: 10.1007/s10865-021-00246-6. Epub 2021 Aug 11. PubMed 34379236 ↗

Study documents

  • Study protocol · Dec 4, 2020
  • Statistical analysis plan · Sep 25, 2015

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02630953
Lead sponsor
University of California, San Diego
Collaborators
National Institute of Nursing Research (NINR)
Responsible party
Dr.Bess Marcus (Professor and Chair, University of California, San Diego) — Principal investigator
First posted
Dec 15, 2015
Start date
Feb 1, 2016
Primary completion
Jul 31, 2019
Completion
Jul 31, 2019
Results posted
Mar 4, 2021
Last update
Mar 4, 2021

Study contacts

Bess H Marcus, PhD
principal investigator · University of California, San Diego

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion